Radiological Description and Impact on Outcome of Postoperative Residue After High-Risk Neuroblastoma Surgery

被引：0

作者：

Irtan, S. ^{[1
]}

Le Pointe, H. Ducou ^{[2
]}

Fayard, C. ^{[3
]}

Gabra, H. ^{[4
]}

Granata, C. ^{[5
]}

Avanzini, S. ^{[6
]}

Pio, L. ^{[6
]}

Gomez-Chacon, J. ^{[7
]}

Braungart, S. ^{[8
]}

Stenman, J. ^{[9
]}

Sundquist, F. ^{[9
]}

Stromgren, J. ^{[10
]}

Plantaz, D. ^{[11
]}

Matthyssens, L. ^{[12
]}

Jauquier, N. ^{[13
]}

Bjornland, K. ^{[14
]}

Ingegerd, A. ^{[15
]}

Cross, K. ^{[16
]}

McHugh, K. ^{[17
]}

Sarnacki, S. ^{[18
]}

机构：

[1] Hop Tousseau, AP HP, Pediat Surg, Paris, France

[2] Hop Trousseau, AP HP, Pediat Radiol, Paris, France

[3] Curie Inst, Pediat Radiol, Paris, France

[4] Newcastle Tyne Upon Hosp NHS Fdn Trust, Newcastle, NSW, Australia

[5] Giannina Gaslini Inst, Pediat Radiol, Genoa, Italy

[6] Giannina Gaslini Inst, Pediat Surg, Genoa, Italy

[7] Hosp La Fe, Pediat Surg, Valencia, Spain

[8] Royal Manchester Childrens Hosp, Pediat Surg, Manchester, Lancs, England

[9] Karolinska Univ Hosp, Pediat Surg & Urol, Stockholm, Sweden

[10] Karolinska Univ Hosp, Pediat Radiol, Stockholm, Sweden

[11] CHU Grenoble, Serv Immunohematooncol Pediat, Grenoble, France

[12] Princess Elisabeth Childrens Hosp, Neonatal & Paediat Surg, Ghent, Belgium

[13] CHUV Lausanne, Serv Chirurg Pediat, Lausanne, Switzerland

[14] Oslo Univ Hosp, Pediat Surg, Oslo, Norway

[15] Oslo Univ Hosp, Pediat Radiol, Oslo, Norway

[16] Pediat Surg, Great Ormond St Children, London, England

[17] Great Ormond St Hosp Sick Children, Pediat Radiol, London, England

[18] Hop Necker Enfants Malad, AP HP, Pediat Surg, Paris, France

来源：

PEDIATRIC BLOOD & CANCER | 2018年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

O-064

引用

页码：S37 / S38

页数：2

共 50 条

[21] An Impact of Etoposide Treatment on Survival for High-Risk Neuroblastoma Patients
Kiyotani, C.
Shioda, Y.
Terashima, K.
Osumi, T.
Kato, M.
Tomizawa, D.
Kanamori, Y.
Fuchimoto, Y.
Nakazawa, A.
Yoshioka, T.
Fuji, H.
Miyazaki, O.
Matsumoto, K.
PEDIATRIC BLOOD & CANCER, 2016, 63 : S198 - S198
[22] Treatment of High-Risk Neuroblastoma
Hizhnikov, A.
Kazancev, A.
Kerimov, P.
Pimenov, R.
PEDIATRIC BLOOD & CANCER, 2017, 64 : S447 - S447
[23] Treatment of High-Risk Neuroblastoma
Sung, Kiwoong
PEDIATRIC BLOOD & CANCER, 2019, 66 : S3 - S3
[24] Telomere Maintenance Mechanisms Define Clinical Outcome in High-Risk Neuroblastoma
Koneru, Balakrishna
Lopez, Gonzalo
Farooqi, Ahsan
Conkrite, Karina L.
Nguyen, Thinh H.
Macha, Shawn J.
Modi, Apexa
Rokita, Jo Lynne
Urias, Eduardo
Hindle, Ashly
Davidson, Heather
Mccoy, Kristyn
Nance, Jonas
Yazdani, Vanda
Irwin, Meredith S.
Yang, Shengping
Wheeler, David A.
Maris, John M.
Diskin, Sharon J.
Reynolds, C. Patrick
CANCER RESEARCH, 2020, 80 (12) : 2663 - 2675
[25] Treatment of High-Risk Neuroblastoma
Krystal, Julie
Foster, Jennifer H.
CHILDREN-BASEL, 2023, 10 (08):
[26] Chemoimmunotherapy for high-risk neuroblastoma
Kushner, Brian H.
LANCET ONCOLOGY, 2017, 18 (07): : 845 - 846
[27] Induction for high-risk neuroblastoma
Kushner, Brian H.
Cheung, Nai-Kong V.
PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 221 - 223
[28] Relapse in the skull after myeloablative therapy for high-risk neuroblastoma
Sangthawan, D
DesRosiers, PM
Randall, ME
Robertson, K
Goebel, S
Fallon, R
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2003, 20 (01) : 23 - 30
[29] Optimizing the Postoperative Management of Children Undergoing Resection of High-Risk Abdominal Neuroblastoma
Lee, William G.
Lascano, Danny
Palmer, Samiza B.
Chen, Stephanie Y.
Mack, Shale J.
Sudharshan, Rasika
Han, Jane S.
Kim, Eugene S.
AMERICAN SURGEON, 2024, 90 (06) : 1290 - 1297
[30] Patterns of Recurrence after Radiation Therapy for High-risk Neuroblastoma
Jo, J. H.
Ahn, S. D.
Choi, E. K.
Kim, J. H.
Lee, S. W.
Song, S. Y.
Yoon, S. M.
Kim, Y. S.
Park, J. H.
Kim, S. S.
Jung, J. H.
RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S883 - S883

← 1 2 3 4 5 →